BI
BioIntelliSense, Inc.
SEC filingOther · Golden, CO
Amount raised$58.3Msold at filing
Total offering$58.4M$662 still open
Investors in the raise14count reported to the SEC
FiledJun 4, 2026first sale Dec 4, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Conlan MaDirector
David WangExecutive Officer, Director
Xinyaun YuDirector
James MaultExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.